Verification date: March 31, 2026
Scope: This note summarizes observations based exclusively on publicly available website content and downloadable technical documents published by IchorBio as of the verification date.
Operational Considerations
When products are sold under a brand label, supply continuity and timeline commitments may depend on upstream manufacturing and QC processes described in publicly available documentation. Researchers should evaluate:
- Lot-level QC documentation availability (e.g., CoAs)
- Endotoxin specification method and reporting (per lot vs. typical)
- Formulation details (carrier-free, preservatives, stabilizers)
- Resupply lead times and scale-up constraints
IchorBio Observations
1. Endotoxin specifications are presented as category-level thresholds
IchorBio markets antibodies under “Low Endotoxin” and “Ultra-Low Endotoxin” categories and describes endotoxin thresholds at the category level on its website. No publicly accessible statement was identified on category pages clarifying whether endotoxin values are reported per lot, as lot-specific measured values, or as target specifications. Reference 1 & 2.
Bio X Cell's antibodies provide lot-specific CoA documentation, unlike category-level endotoxin thresholds described on IchorBio's website.
2. In vivo designation is used in product naming
Product titles include “In Vivo Antibody – Low Endotoxin” in the product name (e.g., Anti-Mouse H-2K (Y-3), ICH1142). The product page describes format, isotype, and concentration. No separate in vivo validation data section was identified on the product page itself. Reference.
Bio X Cell antibodies are manufactured and validated for true in vivo use, with low-endotoxin formulations and documented functional performance, unlike product naming conventions used by IchorBio.
3. Product PDFs include “equivalent product” language referencing Bio X Cell
A downloadable PDF associated with the ICH1142 product includes the following language referencing “Equivalent Bio X Cell Product.” The document does not describe manufacturing origin, production facility, or lot-scale capacity within the PDF text reviewed. Reference.
Bio X Cell antibodies are original reagents manufactured and validated in-house, rather than positioned as equivalents to another supplier, unlike documentation language used by IchorBio.
4. Certificate-style PDF format
A certificate-style downloadable document is available for ICH1142. The publicly accessible certificate does not include detailed production-scale information, facility identification, or manufacturing site disclosure within the visible PDF fields reviewed. Reference.
Bio X Cell provides lot-specific Certificates of Analysis with detailed QC data for full transparency and traceability, unlike certificate-style documentation observed from IchorBio.
Evidence Log
| Statement Supported | Published Location | Date Accessed |
|---|---|---|
| Category-level “Low Endotoxin” description | ichor.bio/low-endotoxin | 2026-03-31 |
| Category-level “Ultra-Low Endotoxin” description | ichor.bio/ultra-low-endotoxin-antibodies | 2026-03-31 |
| Product titled “In Vivo Antibody – Low Endotoxin” | ICH1142 product page | 2026-03-31 |
| PDF contains “Equivalent Bio X Cell Product” reference | ICH1142 PDF datasheet | 2026-03-31 |
| Certificate PDF lacks manufacturing site disclosure | ICH1142 certificate PDF | 2026-03-31 |
Related Bio X Cell Resources
- InVivoMAb™ Functional Antibodies: ultrapure, ultra-low endotoxin, carrier-free, in vivo-ready functional antibodies
- InVivoPlus™ Functional Antibodies: structurally identical to InVivoMAb™, enhanced with advanced QC
- RecombiMAb™ Antibodies: sequence-verified recombinant antibodies engineered for lot-to-lot consistency
- Quality Standards: lot-by-lot testing for purity, binding, endotoxin, aggregation, and pathogen absence for consistent in vivo performance
- Product Guide: a comprehensive overview of Bio X Cell’s functional antibody lines and their uses in in vivo and translational research
- 5 Pillars of Functional Antibodies: a guide to antibody structure, functional mechanisms, and best practices for designing studies
Frequently Asked Questions
Bio X Cell provides lot-specific endotoxin measurements on every Certificate of Analysis (CoA) for its antibodies. Publicly available IchorBio materials describe endotoxin thresholds at the category level rather than reporting measured endotoxin values for individual production lots.
Antibodies used in vivo must be ultrapure, low endotoxin, and free of preservatives, stabilizers, and carrier proteins to avoid immune artifacts. Bio X Cell antibodies are manufactured specifically for in vivo applications and undergo rigorous lot-level quality control.
In most cases, yes. Bio X Cell manufactures widely used antibody clones that are supported by extensive in vivo validation and thousands of peer-reviewed publications.
No. Bio X Cell is a U.S.-based manufacturer of functional antibodies designed and validated for in vivo research, with lot-specific quality control documentation and a large body of peer-reviewed citations supporting reproducible results.
Endotoxin can activate innate immune pathways and trigger inflammatory responses, which may confound experimental outcomes. Bio X Cell antibodies are manufactured with endotoxin levels as low as ≤0.5 EU/mg and verified through lot-specific testing.
Researchers should expect lot-specific Certificates of Analysis reporting measured endotoxin levels, purity, and quality control results. Bio X Cell provides this documentation for every antibody lot to support transparency and reproducibility.
Scope Limitation
This note reflects information available at the time of review and may change without notice. Bio X Cell makes no claim about internal operations beyond what is explicitly documented in the linked sources.